Biocon shares rise 2% after USFDA concludes inspection with 5 observations

Shares of Biocon rose 2% to Rs 364 on Friday, September 5, following the corporate’s announcement that the U.S. Meals and Drug Administration (FDA) has concluded a routine present Good Manufacturing Apply (cGMP) inspection at Biocon Biologics’ Drug Substance facility positioned at its Biocon Campus in Bengaluru, with 5 observations.

The inspection, performed between August 26 and September 3, 2025, lined a number of operational areas, together with drug substance manufacturing models, analytical high quality management laboratories, microbiology labs, and warehouses.

On the conclusion of the inspection, the U.S. FDA issued a Kind 483 with 5 procedural observations.

In accordance with the corporate, these observations should not associated to information integrity, systemic non-compliance, or high quality oversight. Reasonably, they’re procedural in nature and don’t elevate crimson flags over the corporate’s high quality methods or compliance practices.

Biocon Biologics confirmed that it’s going to submit a Corrective and Preventive Motion (CAPA) plan throughout the stipulated timeline and is assured in its capability to deal with all of the observations expeditiously.

Importantly, the corporate said that it doesn’t anticipate any affect on the provision of its business merchandise, assuaging issues over product disruptions or regulatory escalations.“Biocon Biologics will submit a complete Corrective and Preventive Motion (CAPA) plan throughout the stipulated timeline and is assured in its capability to deal with all observations expeditiously. The corporate doesn’t anticipate any affect on provide of its business merchandise,” the corporate mentioned in its press launch.Biocon additionally reiterated its dedication to sustaining the very best requirements of high quality and compliance and warranted stakeholders of continued collaboration with international regulatory businesses.

Additionally learn: You’ll make 12-15% CAGR however don’t make investments for 5-6 month horizons: Raamdeo Agrawal

(Disclaimer: Suggestions, ideas, views and opinions given by the specialists are their very own. These don’t symbolize the views of The Financial Occasions)

A night at Lal Qila, September 27, 2025 — reserved for Occasions Black ICICI Financial institution Credit score Card holders. Entry monumental experiences at timesblack.com